Exact Sciences (EXAS) Free Cash Flow (2010 - 2025)
Exact Sciences (EXAS) free cash flow from Jun 30, 2010 to Dec 31, 2025. The TTM Exact Sciences (EXAS) free cash flow is $357M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Exact Sciences (EXAS) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +378.66% |
| 5 Years TTM | +37.68% |
Annual Free Cash Flow change of Exact Sciences (EXAS)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | $357M | +378.58% |
| 2024 | $75M | +133.48% |
| 2023 | $32M | -107.29% |
| 2022 | -$438M | +84.03% |
| 2021 | -$238M | -429.97% |
| 2020 | $72M | -125.15% |
| 2019 | -$287M | +30.72% |
| 2018 | -$219M | +82.54% |
| 2017 | -$120M | +888.49% |
| 2011 | -$12M | +107.86% |
| 2010 | -$5.85M | N/A |
Comparison Exact Sciences (EXAS) five years free cash flow CAGR with competitors
Exact Sciences (EXAS) five years free cash flow CAGR is 37.68%.
| Ticker | Name | five years Free Cash Flow CAGR | Upside |
|---|---|---|---|
| CDNA | Caredx Inc | 83.64% | +122.00% |
| CRL | Charles River Laboratories International Inc | 42.96% | +14.04% |
| CSTL | Castle Biosciences Inc | 24.94% | -33.80% |
| MEDP | Medpace Holdings Inc | 24.83% | -34.09% |
| PSNL | Personalis Inc | 11.39% | -69.77% |
| ICLR | Icon Plc | 10.77% | -71.43% |
| GH | Guardant Health Inc | 10.63% | -71.79% |
| IDXX | Idexx Laboratories Inc | 10.21% | -72.91% |
| RDNT | Radnet Inc | 8.77% | -76.73% |
| QGEN | Qiagen NV | 6.88% | -81.74% |
| MTD | Mettler-Toledo International Inc | 1.98% | -94.75% |
| ILMN | Illumina Inc | 1.82% | -95.17% |
| IQV | IQVIA Holdings Inc | 0.31% | -99.19% |